Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and bortezomib using 109 propensity score-matched pairs...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Meletios A. Dimopoulos, Robert Z. Orlowski, Thierry Facon, Pieter Sonneveld, Kenneth C. Anderson, Meral Beksac, Lotfi Benboubker, Huw Roddie, Anna Potamianou, Catherine Couturier, Huaibao Feng, Ozlem Ataman, Helgi van de Velde, Paul G. Richardson
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2015-01-01
Online Access:	https://haematologica.org/article/view/7238